SCHEMBL321159

SCHEMBL321159

CC(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)(C)SN=O)C(C)(C)SN=O

nearest known ligand 0.30

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ THRB P10828 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ PTGS2 P35354 1/20 0.30
▸ THPO P40225 1/20 0.30
▸ RECQL P46063 1/20 0.30
▸ BLM P54132 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0914348-A1 POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO DUKE UNIVERSITY MEDICAL CENTER (US) 1999-05-12 — — EP claimed
US-5770645-A THIOLATED NITROSYLATED POLYSACCHARIDE DUKE UNIVERSITY MEDICAL CENTER (US) 1998-06-23 — — US claimed
WO-1998005689-A1 POLYMERS FOR DELIVERING NITRIC OXIDE IN VIVO DUKE UNIVERSITY MEDICAL CENTER (US) 1998-02-12 — — WO claimed
US-20250135170-A1 COMPOSITIONS AND ARTICLES FOR DELIVERING NITRIC OXIDE AND METHODS FOR MAKING AND USING THE SAME UNIV GEORGIA (US) 2025-05-01 — — US disclosed
US-20240269353-A1 NITRIC OXIDE-RELEASING DEVICES KNOW BIO LLC (US) 2024-08-15 — — US disclosed
EP-4340612-A1 NITRIC OXIDE-RELEASING DEVICES KNOW Bio, LLC (US) 2024-03-27 — — EP disclosed
WO-2022246319-A1 NITRIC OXIDE-RELEASING DEVICES KNOW BIO, LLC (US) 2022-11-24 — — WO disclosed
US-20140073602-A9 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2014-03-13 — — US disclosed
US-20130184237-A1 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2013-07-18 — — US disclosed
EP-2591009-A1 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES Fresenius Kabi Deutschland GmbH (DE) 2013-05-15 — — EP disclosed
WO-2012004004-A1 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2012-01-12 — — WO disclosed
US-6403759-B2 SULFIDING/NITROSYLATING CYCLODEXTRINS TO FORM COATING FOR MEDICAL DEVICES (TUBES, CATHETERS) DUKE UNIVERSITY 2002-06-11 — — US disclosed
US-20020062020-A1 High yield S-nitrosylation process HERRMANN ROBERT A (US) 2002-05-23 — — US disclosed
US-6359167-B2 A COMPOUND HAVING A SULFUR-NITRIC OXIDE GROUP (S-N=O) GROUP AS WELL AS A FREE ALCOHOL OR THIOL WITH A HALF-LIFE OF OVER TWELVE HOURS, E.G. S-NITROSO-N-ACETYLPENICILLAMINE; CATHETER COATINGS; SURFACE STERILIZATION DUKE UNIVERSITY 2002-03-19 — — US disclosed
WO-2002016320-A2 HIGH YIELD S-NITROSYLATION PROCESS SCIMED LIFE SYSTEMS, INC. (US) 2002-02-28 — — WO disclosed
US-20010020083-A1 Novel Polymers for Delivering nitric oxide in vivo STAMLER JONATHAN S (US) 2001-09-06 — — US disclosed
US-6232434-B1 MODIFIED POLYSACCHARIDES, CYCLODEXTRINS DUKE UNIVERSITY MEDICAL CENTER 2001-05-15 — — US disclosed
US-6207855-B1 WHICH COMPRISE A STABILIZED S-NITROSYL GROUP AND A FREE ALCOHOL OR A FREE THIOL GROUP. REACTING A POLYTHIOL OR A THIOALCOHOL WITH A NITROSYLATING AGENT, MEDICAL DEVICES COATED WITH THE DISCLOSED COMPOUNDS, NITRIC OXIDE DUKE UNIVERSITY MEDICAL CENTER 2001-03-27 — — US disclosed
US-20010000039-A1 Stable NO-delivering compounds TOONE ERIC J (US) 2001-03-15 — — US disclosed
US-5770645-A THIOLATED NITROSYLATED POLYSACCHARIDE DUKE UNIVERSITY MEDICAL CENTER (US) 1998-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020062020-A1 High yield S-nitrosylation process APOB, TST, NOS2 KDM4E 3955/4885MAPT 987/4885THRB 1790/4885
US-20130184237-A1 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES NOS2, NOS3, NOS1 KDM4E 3621/4885MAPT 4441/4885THRB 4712/4885
US-20140073602-A9 NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES NOS2, NOS3, NOS1 KDM4E 3621/4885MAPT 4441/4885THRB 4712/4885
US-20250135170-A1 COMPOSITIONS AND ARTICLES FOR DELIVERING NITRIC OXIDE AND METHODS FOR MAKING AND USING THE SAME NOS2, NOS1, NOS3 KDM4E 2861/4885MAPT 3861/4885THRB 3954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback